EyePoint, Inc. filed a Form 8-K on November 19, 2026, disclosing that a purported securities class action lawsuit was filed against the company and its executive officers on November 17, 2026, in the U.S. District Court for the Eastern District of New York.

Key Highlights

  • Lawsuit filed: Marco Kälin v. EyePoint, Inc., et al., Civil Action No. 1:26-cv-07418, was filed on November 17, 2026, in the U.S. District Court for the Eastern District of New York.
  • Putative class period: The complaint covers those who purchased or otherwise acquired company securities between May 27, 2025, and August 14, 2026.
  • Allegations: The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, based on purportedly materially false and misleading statements and omissions concerning DURAVYU.
  • Relief sought: The complaint seeks unspecified damages, attorneys' fees, expert fees, and other costs.
  • Company response: EyePoint stated it "believes these allegations lack merit and intends to vigorously defend against this action."

EyePoint Discloses Securities Class Action Tied to DURAVYU Disclosures

According to the filing, the lawsuit was brought by plaintiff Marco Kälin individually and on behalf of a putative class of investors who purchased or otherwise acquired EyePoint securities during the period from May 27, 2025, through August 14, 2026. The case was assigned Civil Action No. 1:26-cv-07418 in the U.S. District Court for the Eastern District of New York.

The filing states that the complaint targets EyePoint, Inc. (NASDAQ:EYPT) and its executive officers, alleging that the defendants made purportedly materially false and misleading statements and omissions concerning the company's lead product candidate, DURAVYU. The alleged conduct is claimed to violate Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. The complaint seeks, among other things, unspecified damages, attorneys' fees, expert fees, and other costs, according to the filing.

The company disclosed its position on the matter, stating it believes the allegations lack merit and that it intends to vigorously defend against the action. The 8-K was signed by Ron Honig, Chief Legal Officer of EyePoint, Inc., on November 19, 2026, and was filed under Item 8.01 (Other Events).

What Was Disclosed

EyePoint, Inc. reported the filing of a purported securities class action lawsuit alleging misleading statements about its DURAVYU product candidate, covering a putative class period from May 27, 2025, to August 14, 2026, and stated it intends to defend against the claims.